KU 487 300 mg Pill: purple, capsule/oblong, 23mm
The pill with imprint KU 487 300 mg (Purple, Capsule/Oblong, 23mm) has been identified as Verapamil Hydrochloride Extended-Release 300 mg and is used for Arrhythmia, Angina, High Blood Pressure, Headache, and Migraine. It belongs to the drug classes calcium channel blockers, group IV antiarrhythmics and is not a controlled substance.
Images for KU 487 300 mg




Verapamil Hydrochloride Extended-Release
- Imprint
- KU 487 300 mg
- Strength
- 300 mg
- Color
- Purple
- Size
- 23.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Calcium channel blockers, Group IV antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Kremers Urban
- Inactive Ingredients
-
D&C Red No. 28,
FD&C Blue No. 1,
FD&C Red No. 40,
fumaric acid,
shellac,
silicon dioxide,
sodium lauryl sulfate,
corn starch,
sucrose,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
62175-0487 | Kremers Urban Pharmaceuticals Inc. |
62175-0572 | Kremers Urban Pharmaceuticals Inc. |
54868-5841 (Discontinued) | Physicians Total Care Inc. (repackager) |
Related images for "KU 487 300 mg"
More about verapamil
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (183)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: calcium channel blockers
- Breastfeeding
- En español
Patient resources
Other brands
Verelan, Calan, Calan SR, Covera-HS, ... +2 more
Professional resources
- Verapamil monograph
- Verapamil (FDA)
- Verapamil Extended Release Capsules (FDA)
- Verapamil Extended Release Tablets (FDA)
- Verapamil Hydrochloride PM (FDA)
Other brands
Verelan, Calan, Calan SR, Verelan PM
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.